moderna stock
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
Peak volume
100+
First seen
2026-08-19
Last seen
2026-08-19
Days trending
1 / 1
Countries
24
Trending timeline
Latest related news (2026-08-19)
-
-
Moderna’s 160% Surge Burns Shorts in ‘Painful’ $5 Billion Loss — Bloomberg.com
-
Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning — The New York Times